0,980  0,001  Cardiovascular analeptic
0,912  0,004  Respiratory analeptic
0,859  0,004  Analeptic
0,728  0,004  UGT1A4 substrate
0,704  0,002  Vasopressin 1A antagonist
0,695  0,002  Vasopressin 1 antagonist
0,684  0,002  Oxytocin antagonist
0,651  0,005  UDP-glucuronosyltransferase substrate
0,651  0,030  Caspase 9 stimulant
0,606  0,002  Vasopressin 2 antagonist
0,608  0,004  Antiacne
0,595  0,002  Vasopressin 1B antagonist
0,589  0,003  Antidiuretic hormone antagonist
0,597  0,014  Bone diseases treatment
0,586  0,004  Antiviral (Influenza A)
0,586  0,016  Sensitization
0,566  0,010  Cardiodepressant
0,575  0,022  Cholesterol antagonist
0,564  0,013  Antipsoriatic
0,553  0,004  Antiviral (Influenza)
0,591  0,051  Apoptosis agonist
0,554  0,014  Antiosteoporotic
0,571  0,032  CYP3A4 substrate
0,537  0,009  Vascular (periferal) disease treatment
0,533  0,007  UGT2B4 substrate
0,536  0,016  AR expression inhibitor
0,520  0,006  Prostatic (benign) hyperplasia treatment
0,536  0,022  5 Hydroxytryptamine release stimulant
0,521  0,018  UGT1A9 substrate
0,506  0,004  Prostate disorders treatment
0,506  0,010  Psychostimulant
0,527  0,040  TNF expression inhibitor
0,492  0,007  Antiseptic
0,485  0,003  UGT2B9 substrate
0,483  0,005  UGT2B15 substrate
0,497  0,021  Apoptosis antagonist
0,480  0,006  Platelet adhesion inhibitor
0,479  0,007  Contraceptive
0,503  0,032  Aldehyde oxidase inhibitor
0,501  0,033  Antipruritic, allergic
0,510  0,052  Antineoplastic (breast cancer)
0,471  0,013  Sedative
0,461  0,009  Hair growth stimulant
0,476  0,030  Antineoplastic (ovarian cancer)
0,466  0,022  Antineoplastic (multiple myeloma)
0,458  0,014  Skin irritative effect
0,458  0,016  UGT1A6 substrate
0,472  0,035  Stroke treatment
0,464  0,036  Teratogen
0,430  0,006  Endometrios treatment
0,472  0,049  Transcription factor NF kappa B inhibitor
0,425  0,007  Lipocortins synthesis antagonist
0,438  0,021  Nitric oxide antagonist
0,423  0,009  UGT2B7 substrate
0,437  0,030  NOS3 expression inhibitor
0,416  0,019  Calcium channel activator
0,411  0,014  Sodium/bile acid cotransporter inhibitor
0,416  0,023  Interleukin 2 agonist
0,404  0,015  Abortion inducer
0,426  0,039  Antihypercholesterolemic
0,426  0,039  Embryotoxic
0,481  0,096  Antiinflammatory
0,422  0,037  Hepatic disorders treatment
0,407  0,028  Cardiotonic
0,379  0,008  Antipruritic
0,412  0,042  FMO1 substrate
0,382  0,012  Antipruritic, non-allergic
0,386  0,018  UGT1A1 substrate
0,434  0,073  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,394  0,037  Antineoplastic (glioma)
0,411  0,057  CYP2C19 inhibitor
0,373  0,019  Antiparkinsonian, rigidity relieving
0,376  0,029  Antineoplastic (renal cancer)
0,346  0,003  UGT2B10 substrate
0,343  0,002  CXC chemokine 3 receptor antagonist
0,379  0,039  Antioxidant
0,370  0,033  Tumour necrosis factor alpha release inhibitor
0,345  0,014  Interferon gamma antagonist
0,394  0,065  CYP2C9 substrate
0,339  0,010  Neurotrophic factor enhancer
0,341  0,016  UGT1A3 substrate
0,387  0,065  Ulceration
0,344  0,025  Anesthetic general
0,371  0,052  ICAM1 expression inhibitor
0,345  0,027  5 Hydroxytryptamine uptake stimulant
0,358  0,041  NOS2 expression inhibitor
0,320  0,005  Estrogen agonist
0,319  0,005  Aromatase inhibitor
0,331  0,022  Hepatoprotectant
0,342  0,037  Antineoplastic (endocrine cancer)
0,353  0,049  CTGF expression inhibitor
0,332  0,039  Antineoplastic (glioblastoma multiforme)
0,298  0,010  Antifungal enhancer
0,293  0,007  Antispirochetal
0,290  0,006  Contraceptive female
0,284  0,004  Antirickettsial
0,281  0,002  RNA-directed RNA polymerase stimulant
0,346  0,067  Prostate cancer treatment
0,322  0,045  Amyotrophic lateral sclerosis treatment
0,314  0,039  GST M1-1 substrate
0,279  0,004  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,319  0,047  Proliferative diseases treatment
0,284  0,013  Cholesterol synthesis inhibitor
0,317  0,049  Antiprotozoal (Leishmania)
0,328  0,061  Antineoplastic (melanoma)
0,316  0,051  Antipyretic
0,328  0,064  Antimycobacterial
0,349  0,087  GST A substrate
0,349  0,087  GABA C receptor rho-3 antagonist
0,312  0,055  Antihypoxic
0,299  0,042  Chemopreventive
0,302  0,047  Interleukin agonist
0,256  0,005  Arachidonic acid antagonist
0,332  0,088  Antileukemic
0,248  0,004  Tocolytic
0,245  0,009  Antiviral (CMV)
0,242  0,011  Microtubule formation inhibitor
0,261  0,034  Male reproductive disfunction treatment
0,226  0,003  UGT2B11 substrate
0,273  0,052  Antiparasitic
0,232  0,011  Choleretic
0,271  0,051  Carcinogenic
0,248  0,029  Anesthetic
0,341  0,123  5 Hydroxytryptamine release inhibitor
0,228  0,011  Androgen antagonist
0,223  0,007  Adenylate cyclase stimulant
0,330  0,114  Antibacterial
0,280  0,065  Chemoprotective
0,271  0,057  Gastrin inhibitor
0,276  0,065  Antineoplastic (cervical cancer)
0,218  0,007  Pregnane X receptor agonist
0,283  0,073  Antituberculosic
0,214  0,005  Cannabinoid CB2 receptor antagonist
0,317  0,115  Histamine release inhibitor
0,204  0,004  Uterine relaxant
0,259  0,059  Cytotoxic
0,285  0,087  Caspase 3 stimulant
0,210  0,014  UGT2B1 substrate
0,198  0,004  Anabolic
0,274  0,081  FMO3 substrate
0,229  0,038  Acaricide
0,195  0,005  CXC chemokine receptor antagonist
0,206  0,017  SULT1A1 substrate
0,231  0,044  Antimutagenic
0,194  0,008  Postmenopausal disorders treatment
0,197  0,017  Alcohol dehydrogenase substrate
0,273  0,094  Antifungal
0,200  0,021  Carcinogenic, group 2B
0,234  0,058  Mutagenic
0,273  0,097  CYP3A4 inhibitor
0,228  0,052  Pneumotoxic
0,233  0,062  RNA-directed DNA polymerase inhibitor
0,230  0,059  Antialcoholic
0,176  0,006  5-Alpha-reductase inhibitor
0,207  0,039  Protein kinase stimulant
0,216  0,049  Muscle relaxant
0,173  0,006  Androgen agonist
0,189  0,025  Antismoking
0,202  0,040  Melanin inhibitor
0,251  0,091  Spasmolytic
0,239  0,079  Tyrosine 3 hydroxylase inhibitor
0,255  0,095  Antiepileptic
0,186  0,026  Farnesoid X receptor antagonist
0,252  0,092  Antineoplastic (pancreatic cancer)
0,204  0,046  Succinate dehydrogenase inhibitor
0,199  0,041  Skeletal muscle relaxant
0,179  0,024  Growth stimulant
0,233  0,080  DNA synthesis inhibitor
0,157  0,005  Anticholelithogenic
0,234  0,082  Antineoplastic (liver cancer)
0,222  0,072  Antimitotic
0,158  0,011  CDC25A inhibitor
0,163  0,020  Ca2+-transporting ATPase inhibitor
0,241  0,098  CYP2C19 substrate
0,199  0,057  VEGF expression inhibitor
0,161  0,020  Estrogen antagonist
0,148  0,008  Glycine receptor antagonist
0,188  0,048  Phobic disorders treatment
0,144  0,005  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,155  0,019  Actinic keratosis treatment
0,165  0,029  Menstruation disorders treatment
0,176  0,042  Alpha-N-acetylglucosaminidase inhibitor
0,145  0,013  Ornithine decarboxylase inhibitor
0,217  0,085  Antihypotensive
0,183  0,052  Interleukin 6 antagonist
0,135  0,004  5-Alpha-reductase 2 inhibitor
0,139  0,008  Na+ K+ transporting ATPase inhibitor
0,228  0,098  Flavin-containing monooxygenase substrate
0,166  0,036  Adenylate cyclase inhibitor
0,144  0,015  Keratolytic
0,181  0,056  Antiviral (Herpes)
0,179  0,054  Diuretic
0,156  0,032  GABA C receptor agonist
0,129  0,004  Estrone sulfatase inhibitor
0,198  0,074  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,130  0,006  Aldosterone antagonist
0,227  0,104  Transcription factor STAT3 inhibitor
0,141  0,021  GST T1-1 substrate
0,180  0,061  Toxic, respiratory center
0,146  0,028  Antiinfertility, female
0,121  0,004  Postcoital contraceptive
0,179  0,062  Phospholipase C inhibitor
0,136  0,021  SULT1E1 substrate
0,119  0,004  Anesthetic inhalation
0,119  0,004  Heme oxygenase stimulant
0,137  0,024  Acetylcholine nicotinic antagonist
0,120  0,007  Bombesin 3 receptor antagonist
0,129  0,016  Estrogen receptor alpha antagonist
0,142  0,029  Chronic obstructive bronchitis treatment
0,133  0,020  Antidote, mercury
0,152  0,040  Glutathione S-transferase substrate
0,203  0,091  Antineoplastic (lymphoma)
0,224  0,112  Cardioprotectant
0,116  0,005  SULT2A1 substrate
0,143  0,031  Sulfotransferase substrate
0,133  0,022  Estrogen receptor beta antagonist
0,133  0,023  ABCA1 expression enhancer
0,121  0,012  Glycine receptor agonist
0,134  0,026  Potassium channel activator
0,127  0,019  Contraceptive male
0,161  0,054  SULT1A3 substrate
0,111  0,004  5-Alpha-reductase 1 inhibitor
0,140  0,034  Antineoplastic, alkylator
0,125  0,019  Glutamate release inhibitor
0,140  0,036  GABA C receptor antagonist
0,117  0,014  Narcotic antagonist
0,146  0,043  Coagulant
0,238  0,136  Antithrombotic
0,111  0,009  Estradiol 17 beta-dehydrogenase inhibitor
0,105  0,004  Adenylate cyclase 1 inhibitor
0,234  0,135  Antineoplastic (lung cancer)
0,102  0,003  Glucose-6-phosphate dehydrogenase inhibitor
0,102  0,005  Lipocortins synthesis agonist
0,222  0,127  Hypoxia-inducible factor 1 alpha inhibitor
0,099  0,004  Pregnane X receptor antagonist
0,221  0,127  CYP1A2 substrate
0,229  0,135  Antineoplastic (brain cancer)
0,156  0,062  Antiparkinsonian, tremor relieving
0,175  0,082  Antiviral (Hepatitis)
0,131  0,039  Anticataract
0,126  0,034  Prolactin inhibitor
0,116  0,024  Bile acid receptor antagonist
0,144  0,055  Retinoprotector
0,190  0,101  VCAM1 expression inhibitor
0,116  0,027  Transcription factor NF kappa B stimulant
0,114  0,028  Inducible nitric-oxide synthase inhibitor
0,241  0,155  Immunosuppressant
0,205  0,119  Antineoplastic (sarcoma)
0,089  0,005  Potassium channel Kv1.1 blocker
0,139  0,054  Anesthetic local
0,154  0,069  CF transmembrane conductance regulator agonist
0,200  0,116  DNA damaging
0,157  0,074  Eye irritation, high
0,200  0,117  Superoxide dismutase inhibitor
0,151  0,069  Movement disorders treatment
0,135  0,053  CC chemokine 6 receptor antagonist
0,103  0,021  Estrogen-related receptor beta agonist
0,084  0,005  GABA uptake inhibitor
0,114  0,035  Paget's disease treatment
0,096  0,017  Carbonic anhydrase VB inhibitor
0,207  0,129  Antineoplastic (colorectal cancer)
0,132  0,054  Autism spectrum disorders treatment
0,137  0,060  Antihemorrhagic
0,172  0,096  CYP2B6 inhibitor
0,199  0,124  Antineoplastic (colon cancer)
0,091  0,016  Antimycoplasmal
0,088  0,013  Estrogen receptor beta agonist
0,114  0,039  Tourette's syndrome treatment
0,095  0,020  Antidote, organophosphates
0,127  0,053  Antiviral (Influenza B)
0,196  0,123  Immunostimulant
0,101  0,028  Cannabinoid receptor antagonist
0,126  0,053  Antifungal (Pneumocystis)
0,125  0,053  TRPA1 agonist
0,134  0,063  Cyclooxygenase 3 inhibitor
0,081  0,011  Estrogen receptor alpha agonist
0,074  0,005  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,144  0,075  Genotoxic
0,095  0,027  Carbonic anhydrase VA inhibitor
0,202  0,135  Transcription factor STAT inhibitor
0,073  0,006  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,132  0,065  Antihyperlipoproteinemic
0,077  0,011  Progesterone antagonist
0,193  0,128  Radioprotector
0,071  0,006  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,071  0,006  Parathyroid hormone antagonist
0,071  0,007  Farnesoid X receptor agonist
0,136  0,071  Bone formation stimulant
0,177  0,113  5 Hydroxytryptamine 3E antagonist
0,110  0,046  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,159  0,095  Diabetic nephropathy treatment
0,071  0,010  Retinoid X receptor agonist
0,091  0,030  Carbonic anhydrase V inhibitor
0,159  0,099  Antihelmintic
0,106  0,047  Posttraumatic stress disorder treatment
0,067  0,008  Microtubule stabilization
0,158  0,100  LDLR expression enhancer
0,123  0,066  DNA polymerase I inhibitor
0,118  0,060  Photosensitizer
0,196  0,139  Renal disease treatment
0,148  0,092  Antiviral (Hepatitis C)
0,079  0,025  Glutamate (mGluR6) antagonist
0,057  0,006  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,130  0,079  Psychosexual dysfunction treatment
0,061  0,011  Glucocorticoid antagonist
0,104  0,056  UDP-glucose 4-epimerase inhibitor
0,175  0,127  Cytostatic
0,143  0,095  Uterine stimulant
0,088  0,042  Nicotinic alpha4beta2 receptor antagonist
0,108  0,063  Ferrochelatase inhibitor
0,124  0,079  Vanilloid 1 agonist
0,162  0,117  Insulin sensitizer
0,074  0,030  Antihemophilic
0,174  0,131  Acute neurologic disorders treatment
0,057  0,016  Geranyltranstransferase inhibitor
0,095  0,053  Triose-phosphate isomerase inhibitor
0,103  0,062  Adenylate kinase inhibitor
0,099  0,057  Lanosterol 14 alpha demethylase inhibitor
0,135  0,095  Heat shock protein 70 antagonist
0,072  0,031  NMDA 2C receptor antagonist
0,117  0,077  Cholinergic antagonist
0,115  0,075  Acetylcholine antagonist
0,059  0,020  Mineralocorticoid receptor antagonist
0,069  0,030  Cannabinoid CB2 receptor agonist
0,177  0,138  Hypoglycemic
0,047  0,009  Tubulin agonist
0,098  0,061  Interleukin 1 beta converting enzyme inhibitor
0,222  0,185  Antiobesity
0,051  0,015  Hypogonadism treatment
0,048  0,012  Cholesterol absorption inhibitor
0,104  0,069  DOPA decarboxylase inhibitor
0,057  0,023  Potassium channel Kv1.3 blocker
0,204  0,171  Vasodilator, peripheral
0,038  0,005  Hedgehog signaling activator
0,078  0,045  Vanilloid 4 agonist
0,047  0,015  Retinoid X alpha receptor agonist
0,051  0,020  Guanylate cyclase inhibitor
0,059  0,028  Nicotinic alpha3beta2 receptor antagonist
0,032  0,003  Telomerase stimulant
0,137  0,108  Carcinogenic, group 1
0,140  0,112  Hearing loss treatment
0,074  0,045  Phosphofructokinase-1 inhibitor
0,072  0,044  Premenstrual syndrome treatment
0,132  0,104  Growth hormone agonist
0,040  0,013  Carboxypeptidase B inhibitor
0,156  0,129  Growth factor agonist
0,033  0,006  Progesterone agonist
0,070  0,043  Glutamate (mGluR7) antagonist
0,107  0,082  Mental retardation treatment
0,187  0,163  CYP2D6 inhibitor
0,147  0,122  P-glycoprotein inhibitor
0,086  0,062  Sodium/hydrogen exchanger 5 inhibitor
0,067  0,043  Cannabinoid receptor agonist
0,042  0,020  Retinoid X receptor antagonist
0,058  0,036  Acetyl-CoA transferase 2 inhibitor
0,066  0,044  Hypercalcemia treatment
0,103  0,081  Acetylcholine release stimulant
0,041  0,019  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,026  0,005  NMDA receptor phencyclidine site antagonist
0,030  0,008  GRP78 expression inhibitor
0,050  0,029  Glucose-6-phosphate isomerase inhibitor
0,067  0,047  MDM2 inhibitor
0,038  0,018  Retinoid X alpha receptor antagonist
0,028  0,008  Corticosteroid-like
0,070  0,052  Phospholipase D inhibitor
0,027  0,009  Vitamin D receptor antagonist
0,170  0,152  Nitric-oxide synthase stimulant
0,063  0,046  Hyperparathyroidism treatment
0,042  0,024  Membrane dipeptidase inhibitor
0,035  0,018  Cholesterol ester transfer protein antagonist
0,129  0,113  Antihelmintic (Nematodes)
0,065  0,049  Neuronal nicotinic receptor antagonist
0,018  0,003  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,027  0,012  Retinoid X gamma receptor agonist
0,023  0,009  Retinoid X beta receptor antagonist
0,053  0,039  GABA receptor antagonist
0,095  0,081  Excitatory amino acid transporter EAAC1 inhibitor
0,029  0,015  Nicotinic acid receptor 2 antagonist
0,043  0,029  Alpha 1L adrenoreceptor agonist
0,055  0,041  Argininosuccinate synthase inhibitor
0,043  0,030  Heme oxygenase inhibitor
0,093  0,080  AMP-activated protein kinase stimulant
0,056  0,043  Botulinum neurotoxin type A inhibitor
0,082  0,070  NADH dehydrogenase inhibitor
0,028  0,016  Retinoid X gamma receptor antagonist
0,032  0,021  ATP citrate lysase inhibitor
0,091  0,079  Antiviral (Poxvirus)
0,013  0,002  Transcortin receptor antagonist
0,067  0,057  Epoxide hydrolase inhibitor
0,026  0,016  Vanilloid 2 agonist
0,078  0,069  Sleep apnea treatment
0,023  0,014  Retinoic acid gamma receptor agonist
0,098  0,089  Proteasome inhibitor
0,037  0,028  Glutamate (mGluR8) agonist
0,097  0,089  Carcinogenic, group 3
0,097  0,089  Antitussive
0,017  0,010  Vitamin D receptor agonist
0,056  0,048  Carbamoyl phosphate synthetase inhibitor
0,023  0,016  Retinoic acid receptor agonist
0,051  0,044  Alcohol oxidase inhibitor
0,036  0,029  Delayed rectifier potassium channel blocker
0,031  0,024  Glutamate (mGluR3) agonist
0,124  0,117  GABA C receptor rho-2 antagonist
0,139  0,132  Non-steroidal antiinflammatory agent
0,109  0,102  Cocaine dependence treatment
0,092  0,086  Cystathionine beta-synthase inhibitor
0,046  0,040  HCV NS3/NS4A protease inhibitor
0,048  0,042  Aconitate hydratase inhibitor
0,020  0,015  Retinoid X beta receptor agonist
0,065  0,061  Porphobilinogen synthase inhibitor
0,010  0,006  Progesterone receptor A antagonist
0,071  0,068  Chymotrypsin inhibitor
0,015  0,012  Antibiotic Tetracycline-like
0,060  0,057  Calcium channel P-type blocker
0,052  0,050  Cannabinoid CB1 receptor agonist
0,076  0,074  Falcipain 2 inhibitor
0,038  0,036  Kainate receptor agonist
0,025  0,024  Thymidine kinase (Herpes simplex virus 1) inhibitor
0,036  0,035  Dopamine D5 agonist
0,048  0,047  Alpha-mannosidase inhibitor
0,077  0,077  Falcipain inhibitor
0,030  0,030  Antihyperaldosteronism

